Trial: 202107134

A Phase Ib Study of Isatuximab, Velcade, and Dexamethasone in Patients with Multiple Myeloma and Severe Kidney Disease

Phase

I

Principal Investigator

Stockerl-Goldstein, Keith

Disease Site

Multiple Myeloma

Learn more about this study at: clinicaltrials.gov